MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
94 hedge funds and large institutions have $226M invested in Marinus Pharmaceuticals, Inc in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
42% less call options, than puts
Call options by funds: $819K | Put options by funds: $1.41M
Holders
94
Holding in Top 10
3
Calls
$819K
Puts
$1.41M
Top Buyers
| 1 | +$14.6M | |
| 2 | +$12.2M | |
| 3 | +$11.4M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$5.08M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.81M |
Top Sellers
| 1 | -$2.11M | |
| 2 | -$1.97M | |
| 3 | -$781K | |
| 4 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
-$683K |
| 5 |
JPMorgan Chase & Co
New York
|
-$675K |